Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
J Clin Neurosci ; 77: 41-48, 2020 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-32409219

RESUMEN

Hypnosis could extend the time of Intraoperative Neuropsychological Testing and Brain Mapping in Awake Surgery. A clinical validation for the Hypnosis aided AS (HAs) is still ongoing and further evidences are required. The objective of the present study is to compare two homogeneous cohorts of patients undergoing AS, the first with the aid of the hypnosis and the second according to a standard AS (SAs) protocols. The clinical, radiological and surgical data of two comparable procedures cohorts were retrospectively examined for the present study. All surgeries in Group A were performed with a HAs protocol. Procedures belonging to Group B were performed with a SAs protocol. Endpoints: to compare 1. Incidence of complications in the immediate postoperative period, 2. Clinical and neurological status in the immediate postoperative period and 30 days after surgery, 3. Duration of surgical interventions, 4. Extent of Resection (EOR). The final cohort is composed of 15 procedures; 6 belonging to Group A and 9 to Group B. The different methods outline statistically comparable results from the clinical (Neurological outcomes) both in the postoperative period and one month after surgery and from the surgical point of view (comparable EOR). The incidence of complications is comparable either. The duration of the procedures was significantly longer in HAs group. Hypnosis is a promising approach to increasing the duration of intraoperative "testability" of patients at the price of a longer operative time. A specific professional is needed to induce hypnosis in the difficult intraoperative setting.


Asunto(s)
Neoplasias Encefálicas/cirugía , Manejo de la Enfermedad , Glioma/cirugía , Hipnosis/métodos , Monitoreo Intraoperatorio/métodos , Vigilia , Adulto , Mapeo Encefálico/métodos , Neoplasias Encefálicas/diagnóstico por imagen , Neoplasias Encefálicas/psicología , Estudios de Cohortes , Craneotomía/métodos , Femenino , Glioma/diagnóstico por imagen , Glioma/psicología , Humanos , Masculino , Persona de Mediana Edad , Clasificación del Tumor/métodos , Pruebas Neuropsicológicas , Tempo Operativo , Estudios Retrospectivos
3.
World Neurosurg ; 121: e882-e891, 2019 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-30315969

RESUMEN

BACKGROUND: Hypnosis is a technique that could aid awake surgery protocols. The aim of the present study is to describe the results of a preliminary experience of a cohort of patients operated on with an original protocol of hypnosis-aided awake surgery (HAS). METHODS: All patients were operated on with the aid of HAS and their data were retrospectively reviewed. A thorough literature review was conducted to compare the results of HAS with the standard awake surgery protocol regarding 1) the incidence of intraoperative pain; 2) the overall incidence of complications; 3) the length of time in which the patients were suitable for intraoperative neuropsychological testing; and 4) the incidence of gross total resection. The comparison presented a notably high statistical impact (1-ß = 0.90-0.93 for α = 0.05; effect size, 0.5). RESULTS: The final cohort comprised 6 patients from our institution and 43 records retrieved in the relevant literature underwent HAS for intrinsic brain tumor treatment. This cohort was compared with cohorts of patients who were considered eligible through a literature review. HAS showed a statistically significant superiority in the first 3 outcome variables, whereas the incidence of gross total resection favored the standard awake approaches. CONCLUSIONS: According to the results, hypnosis-aided resection of intrinsic brain tumor located in eloquent areas is safe and effective, although dissociation phenomena deserve further investigation to be completely understood.


Asunto(s)
Neoplasias Encefálicas/psicología , Neoplasias Encefálicas/cirugía , Craneotomía/métodos , Hipnosis/métodos , Vigilia/fisiología , Adulto , Anciano , Bases de Datos Bibliográficas/estadística & datos numéricos , Femenino , Humanos , Estado de Ejecución de Karnofsky , Imagen por Resonancia Magnética , Masculino , Monitoreo Intraoperatorio , Estudios Retrospectivos , Estadísticas no Paramétricas , Adulto Joven
4.
Anticancer Res ; 38(4): 2423-2427, 2018 04.
Artículo en Inglés | MEDLINE | ID: mdl-29599372

RESUMEN

BACKGROUND: Patients affected by glioblastoma often develop cerebral oedema as a life-threatening complication. Although there is no approved pharmacological intervention, such cerebral oedema is usually treated with dexamethasone. Dexamethasone has been shown in experimental studies to reduce cerebral oedema with only few mineralocorticoid side-effects. The goal of our study was to examine its efficacy in reducing the emergence of neurological deficits during the Stupp protocol. PATIENTS AND METHODS: We studied a retrospective cohort of 459 patients, assigned in controlled groups: in group A, patients received radiochemotherapy followed by adjuvant chemotherapy; in group B, patients received an equivalent combined treatment with dexamethasone. RESULTS: The frequency of neurological symptoms was significantly lower in dexamethasone-treated patients. CONCLUSION: Early diagnosis and prevention of cerebral oedema are important because functional consequences can be anticipated with an appropriate medical treatment. Thus, our study reveals that dexamethasone acts to prevent the appearance of neurological symptoms in patients with brain tumour.


Asunto(s)
Edema Encefálico/prevención & control , Neoplasias Encefálicas/radioterapia , Terapia Combinada/métodos , Irradiación Craneana/efectos adversos , Glioblastoma/radioterapia , Adulto , Anciano , Anciano de 80 o más Años , Edema Encefálico/etiología , Neoplasias Encefálicas/complicaciones , Neoplasias Encefálicas/patología , Quimioterapia Adyuvante , Dexametasona/administración & dosificación , Femenino , Glioblastoma/complicaciones , Glioblastoma/patología , Humanos , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Adulto Joven
5.
Oncotarget ; 7(21): 30781-96, 2016 May 24.
Artículo en Inglés | MEDLINE | ID: mdl-27096953

RESUMEN

Malignant gliomas are among the most frequent and aggressive cerebral tumors, characterized by high proliferative and invasive indexes. Standard therapy for patients, after surgery and radiotherapy, consists of temozolomide (TMZ), a methylating agent that blocks tumor cell proliferation. Currently, there are no therapies aimed at reducing tumor cell invasion. Ion channels are candidate molecular targets involved in glioma cell migration and infiltration into the brain parenchyma. In this paper we demonstrate that: i) blockade of the calcium-activated potassium channel KCa3.1 with TRAM-34 has co-adjuvant effects with TMZ, reducing GL261 glioma cell migration, invasion and colony forming activity, increasing apoptosis, and forcing cells to pass the G2/M cell cycle phase, likely through cdc2 de-phosphorylation; ii) KCa3.1 silencing potentiates the inhibitory effect of TMZ on glioma cell viability; iii) the combination of TMZ/TRAM-34 attenuates the toxic effects of glioma conditioned medium on neuronal cultures, through a microglia dependent mechanism since the effect is abolished by clodronate-induced microglia killing; iv) TMZ/TRAM-34 co-treatment increases the number of apoptotic tumor cells, and the mean survival time in a syngeneic mouse glioma model (C57BL6 mice implanted with GL261 cells); v) TMZ/TRAM-34 co-treatment reduces cell viability of GBM cells and cancer stem cells (CSC) freshly isolated from patients.Taken together, these data suggest a new therapeutic approach for malignant glioma, targeting both glioma cell proliferating and migration, and demonstrate that TMZ/TRAM-34 co-treatment affects both glioma cells and infiltrating microglia, resulting in an overall reduction of tumor cell progression.


Asunto(s)
Antineoplásicos Alquilantes/uso terapéutico , Neoplasias Encefálicas/tratamiento farmacológico , Dacarbazina/análogos & derivados , Glioma/tratamiento farmacológico , Canales de Potasio de Conductancia Intermedia Activados por el Calcio/antagonistas & inhibidores , Pirazoles/farmacología , Animales , Apoptosis/efectos de los fármacos , Neoplasias Encefálicas/mortalidad , Proteína Quinasa CDC2/metabolismo , Línea Celular Tumoral , Movimiento Celular/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Dacarbazina/farmacología , Dacarbazina/uso terapéutico , Sinergismo Farmacológico , Quimioterapia Combinada , Puntos de Control de la Fase G2 del Ciclo Celular/efectos de los fármacos , Glioma/mortalidad , Humanos , Canales de Potasio de Conductancia Intermedia Activados por el Calcio/genética , Estimación de Kaplan-Meier , Ratones , Ratones Endogámicos C57BL , Microglía/efectos de los fármacos , Microglía/metabolismo , Neoplasias Experimentales/tratamiento farmacológico , Neoplasias Experimentales/mortalidad , Células Madre Neoplásicas/efectos de los fármacos , Fosforilación , Cultivo Primario de Células , Pirazoles/uso terapéutico , Temozolomida
6.
J Neurosurg Spine ; 7(5): 571-4, 2007 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-17977203

RESUMEN

A spinal epidural hematoma is an extremely rare complication of cervical spine manipulation therapy (CSMT). The authors present the case of an adult woman, otherwise in good health, who developed Brown-Séquard syndrome after CSMT. Decompressive surgery performed within 8 hours after the onset of symptoms allowed for complete recovery of the patient's preoperative neurological deficit. The unique feature of this case was the magnetic resonance image showing increased signal intensity in the paraspinal musculature consistent with a contusion, which probably formed after SMT. The pertinent literature is also reviewed.


Asunto(s)
Vértebras Cervicales , Hematoma Espinal Epidural/etiología , Manipulación Quiropráctica/efectos adversos , Vértebras Torácicas , Femenino , Hematoma Espinal Epidural/diagnóstico , Hematoma Espinal Epidural/terapia , Humanos , Persona de Mediana Edad
7.
J Neurosurg ; 105(5): 789-96, 2006 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-17121149

RESUMEN

Despite the significant Italian tradition of important anatomical studies, an outdated law historically influenced by the Catholic church restricts the use of cadavers for teaching and scientific purposes. The object of the present paper was to trace the historical evolution of the Italian anatomical tradition, particularly neuroanatomical studies, in relation to the juridical regulations on the use of cadavers today. Special attention was paid to the opportunities offered to neurosurgery by using cadavers and to the scientific and social issues in neurosurgical training in the twenty-first century. Considering the new Common European Constitution, the authors advocate a political solution from the European community to improve the quality of training in the disciplines with a social impact such as neurosurgery.


Asunto(s)
Disección/historia , Neuroanatomía/historia , Neurocirugia/historia , Cadáver , Disección/legislación & jurisprudencia , Historia del Siglo XV , Historia del Siglo XVI , Historia del Siglo XVII , Historia del Siglo XVIII , Historia del Siglo XIX , Historia del Siglo XX , Historia Antigua , Historia Medieval , Humanos , Italia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA